Synlait Milk (SML) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
3 Feb, 2026Opening remarks and agenda
Meeting held in Christchurch and online, with clear instructions for voting and Q&A participation provided to attendees.
Chair and CEO addresses opened the meeting, followed by resolutions, voting, and other business.
Four ordinary resolutions on the agenda: two Director elections, Auditor's remuneration, and the sale of North Island assets.
Board and executive committee updates
Board includes independent and Bright Dairy-appointed directors, with Paul Washer retiring and Julia Zhu joining.
Board remains at six Directors, with two Independent Directors; no immediate search for a replacement after Paul Washer's departure.
Audit and Risk Committee now chaired by Julia Zhu, with a commitment to review governance structure in May 2026.
Audit & Risk and People, Environment & Governance committees chaired by Julia Zhu and George Adams, respectively.
Board acknowledges current structure does not fully align with NZX Corporate Governance Code but is considered appropriate for now.
Financial performance review
FY2025 described as a period of intense challenge, including solvency issues, disputes, equity raising, and manufacturing setbacks.
$43.5 million in costs from manufacturing challenges in FY2025, with some costs expected to continue into FY2026.
$130m Bright Dairy shareholder loan and equity raise in 2024 supported survival and debt reduction.
$180m bond redemption completed by end of 2024.
Return to profitability signaled in March 2025, with new milk premiums and secured supply.
Sale of North Island assets to Abbott for NZD 307 million will significantly reduce debt and reset the balance sheet.
Peak debt projected to drop from $550 million to $250 million after asset sale, with only working capital debt remaining.
Latest events from Synlait Milk
- North Island asset sale to Abbott and debt reduction strategy mark a pivotal reset.SML
Investor presentation - Major debt reduction, operational focus, and sustainability targets set for FY25.SML
Investor presentation - Net loss of $80.6 million, high debt, and asset sale drive a challenging but hopeful recovery.SML
H1 2026 - North Island asset sale and record FY25 results drive strategic reset and debt reduction.SML
H2 2025 - Major loss, balance sheet reset, and FY25 growth priorities with strong shareholder backing.SML
AGM 2024 - Significant losses and deleveraging efforts defined the year, with recovery hinging on milk supply.SML
H2 2024 - Profitability restored with strong EBITDA growth, reduced debt, and improved milk supply outlook.SML
H1 2025